Core D: University of Kentucky Alzheimer's Disease Core Center

核心 D:肯塔基大学阿尔茨海默病核心中心

基本信息

  • 批准号:
    10261965
  • 负责人:
  • 金额:
    $ 28.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract: Neuropathology Core The overall objective of the Neuropathology Core of the UK-ADRC is to support research on normal brain aging, presymptomatic AD, MCI, early and late AD, mixed dementia syndromes, and other dementing disorders. Autopsies will be performed by our Rapid Autopsy Team on longitudinally followed subjects from our Clinical Core. We will perform short post-mortem interval autopsies, and we will maintain a high autopsy rate. This Core is optimally tailored to help address important research questions. The Core will provide brain tissue, CSF and other biospecimens for investigators at UK, other ADRCs, and outside investigators. The Core will also provide consensus conference determined diagnoses, quantitation of neurofibrillary tangles, neuritic plaques, and diffuse plaques from 8 brain regions, Ab quantitation, Braak staging, CERAD, and NIA-Reagan Institute staging on all autopsied cases, along with evaluation of alpha-synuclein and TDP-43 proteinopathy. This brain bank has been operating continuously for over three decades with a strong track record, so special care will be taken to ensure diagnostic excellence, consistency, and continuity. The Core will maintain a tissue bank of the above specimens and frozen serum, plasma, buffy coats and CSF from living patients. Special emphasis will be placed on generating rigorous quantititative pathologic metrics from digital pathology, and providing investigators with specimens from cognitively intact control subjects with no Ab deposition and sparse tau pathology (successful cerebral aging) and many cases with mixed pathologies. Providing these samples will contribute to clinical-pathological correlation studies and cutting-edge research that include sponsored studies related to AD genomics, oxidative stress, hippocampal sclerosis/LATE, dementia with Lewy bodies, Down syndrome, and neuroinflammation. Frequent consensus conferences will be held with the Clinical, Biomarker, and Data Management and Statistics Cores to help define clinical-pathological diagnoses on all autopsied subjects. The Neuropathology Core is strongly integrated with other Cores of the UK-ADRC, and exploits unique opportunities to conduct clinical-pathological correlative studies on longitudinally followed subjects. Through these methods we will better understand normal brain aging and the transition to multi- etiology dementia with the goal of contributing to therapeutic or preventive measures. The Neuropathology Core complements the other Cores of the UK-ADRC to provide extremely essential diagnoses and tissue samples that are required for many cutting-edge researchers at the University of Kentucky and elsewhere. We will build on our track record of excellence using innovative tools related to brain autopsies, neuropathological diagnoses, tissue banking, and clinical-pathological correlation. Our specific aims are: Aim 1: Provide state-of-the-art neuropathological and biospecimen repository services Aim 2: Leverage neuropathology resources and expertise to contribute to research efforts Aim 3: Integrate with other cores to contribute to administrative, research and educational missions
项目摘要/摘要:神经病理学核心 UK-ADRC神经病理学核心的总体目标是支持对正常大脑的研究 老年、症状前AD、MCI、早期和晚期AD、混合性痴呆综合征和其他痴呆 紊乱尸检将由我们的快速尸检团队对我们的纵向跟踪受试者进行。 临床核心。我们将进行短时间的尸检,我们将保持高尸检率。 这个核心是最佳定制,以帮助解决重要的研究问题。内核会提供脑组织 供英国研究者、其他ADRC和外部研究者使用的CSF和其他生物标本。芯会 还提供共识会议确定的诊断,神经系统缠结的定量,神经炎 斑块和8个脑区的弥漫性斑块、Ab定量、Braak分期、CERAD和NIA-Reagan 对所有尸检病例进行研究所分期,沿着α-突触核蛋白和TDP-43蛋白病的评价。 这个大脑银行已经连续运作了三十多年,有着良好的记录,所以很特别。 将注意确保诊断的卓越性、一致性和连续性。内核会维持一个组织 上述标本库和冷冻血清、血浆、血沉棕黄层和来自活患者的CSF。特别 重点将放在从数字病理学中生成严格的定量病理学指标上, 为研究者提供来自无Ab沉积的认知完整对照受试者的标本, 稀疏tau病理学(成功的脑老化)和许多具有混合病理学的病例。提供这些 样本将有助于临床病理相关性研究和前沿研究,包括 申办的与AD基因组学、氧化应激、海马硬化/LATE、路易氏痴呆相关的研究 身体、唐氏综合症和神经炎症。将经常与各缔约方举行协商一致会议, 临床、生物标志物、数据管理和统计核心,帮助定义临床病理诊断 所有尸检对象的数据神经病理学核心与UK-ADRC的其他核心紧密结合, 并利用独特的机会进行纵向随访的临床病理相关研究 科目通过这些方法,我们将更好地了解正常的大脑老化和过渡到多- 病因学痴呆,目的是有助于治疗或预防措施。神经病理学 核心补充了英国ADRC的其他核心,以提供极其重要的诊断和组织 肯塔基州和其他地方的许多尖端研究人员所需的样本。我们 将建立在我们卓越的记录,使用创新的工具,与大脑解剖,神经病理学 诊断、组织库和临床-病理相关性。我们的具体目标是: 目标1:提供最先进的神经病理学和生物标本储存服务 目标2:利用神经病理学资源和专业知识为研究工作做出贡献 目标3:与其他核心整合,为行政、研究和教育任务做出贡献

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER T. NELSON其他文献

PETER T. NELSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER T. NELSON', 18)}}的其他基金

Core D: University of Kentucky Alzheimer's Disease Core Center
核心 D:肯塔基大学阿尔茨海默病核心中心
  • 批准号:
    10662352
  • 财政年份:
    2021
  • 资助金额:
    $ 28.57万
  • 项目类别:
Core D: University of Kentucky Alzheimer's Disease Core Center
核心 D:肯塔基大学阿尔茨海默病核心中心
  • 批准号:
    10459469
  • 财政年份:
    2021
  • 资助金额:
    $ 28.57万
  • 项目类别:
Novel misfolded proteins in ADRD: proteomics, genetics, and clinical-pathological correlations
ADRD 中的新型错误折叠蛋白:蛋白质组学、遗传学和临床病理相关性
  • 批准号:
    9905466
  • 财政年份:
    2019
  • 资助金额:
    $ 28.57万
  • 项目类别:
Novel pathogenetic mechanism for hippocampal sclerosis, a common Alzheimers mimic
海马硬化的新发病机制,一种常见的阿尔茨海默病模拟
  • 批准号:
    9912063
  • 财政年份:
    2017
  • 资助金额:
    $ 28.57万
  • 项目类别:
Novel pathogenetic mechanism for hippocampal sclerosis, a common Alzheimers mimic
海马硬化的新发病机制,一种常见的阿尔茨海默病模拟
  • 批准号:
    9402752
  • 财政年份:
    2017
  • 资助金额:
    $ 28.57万
  • 项目类别:
Testing a therapeutic strategy for hippocampal sclerosis of aging, a key AD mimic
测试老年海马硬化的治疗策略,这是一种关键的 AD 模拟
  • 批准号:
    9055456
  • 财政年份:
    2016
  • 资助金额:
    $ 28.57万
  • 项目类别:
Sexually dimorphic miR-497 regulates alpha-synuclein and alpha-synucleinopathy
性二态性 miR-497 调节 α-突触核蛋白和 α-突触核蛋白病
  • 批准号:
    8638195
  • 财政年份:
    2013
  • 资助金额:
    $ 28.57万
  • 项目类别:
CELLULAR CHANGES ALTERING SYNAPTIC CONNECTIVITY IN PRECLINICAL AD
临床前 AD 中细胞变化改变突触连接
  • 批准号:
    9282762
  • 财政年份:
    2013
  • 资助金额:
    $ 28.57万
  • 项目类别:
CELLULAR CHANGES ALTERING SYNAPTIC CONNECTIVITY IN PRECLINICAL AD
临床前 AD 中细胞变化改变突触连接
  • 批准号:
    9084441
  • 财政年份:
    2013
  • 资助金额:
    $ 28.57万
  • 项目类别:
Sexually dimorphic miR-497 regulates alpha-synuclein and alpha-synucleinopathy
性二态性 miR-497 调节 α-突触核蛋白和 α-突触核蛋白病
  • 批准号:
    8739560
  • 财政年份:
    2013
  • 资助金额:
    $ 28.57万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 28.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 28.57万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 28.57万
  • 项目类别:
    Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 28.57万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 28.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 28.57万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 28.57万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 28.57万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 28.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 28.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了